Decision Diagnostics Stock Performance
| DECN Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Decision Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Decision Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Decision Diagnostics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
Last Split Factor 1.1:1 | Last Split Date 2011-12-28 |
1 | FDA approves IsoPSA diagnostic test to improve prostate biopsy decision-making - Medical Economics | 12/01/2025 |
2 | Selling US1.8m Of Stock Was Lucrative Decision For BlackSky Technology Insiders - simplywall.st | 12/08/2025 |
3 | Diagnostics Limited Stock Rallies - IPO Market Watch Invest Smarter With Data-Driven Models - Bollywood Helpline | 12/16/2025 |
4 | CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan - The Globe and Mail | 12/29/2025 |
5 | Antech launches next-generation diagnostic innovations to advance clinical decision-making at VMX 2026 - Yahoo Finance Singapore | 01/13/2026 |
6 | Stock index futures rise ahead of Fed decision - MSN | 01/28/2026 |
| Begin Period Cash Flow | -185.7 K | |
| Total Cashflows From Investing Activities | 50.3 K |
Decision Diagnostics Relative Risk vs. Return Landscape
If you would invest 0.01 in Decision Diagnostics on November 4, 2025 and sell it today you would earn a total of 0.00 from holding Decision Diagnostics or generate 0.0% return on investment over 90 days. Decision Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Decision, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Decision Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Decision Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Decision Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Stock index futures rise ahead of Fed decision - MSN |
Decision Diagnostics Fundamentals Growth
Decision Stock prices reflect investors' perceptions of the future prospects and financial health of Decision Diagnostics, and Decision Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Decision Stock performance.
| Return On Equity | -81.61 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 3.06 M | ||||
| Shares Outstanding | 357.87 M | ||||
| Price To Earning | (0.33) X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 1.98 M | ||||
| Gross Profit | 462.23 K | ||||
| EBITDA | (2.41 M) | ||||
| Net Income | (29.67 M) | ||||
| Cash And Equivalents | 210.85 K | ||||
| Total Debt | 2.93 M | ||||
| Debt To Equity | 9.05 % | ||||
| Current Ratio | 0.25 X | ||||
| Cash Flow From Operations | (1.4 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Market Capitalization | 35.79 K | ||||
| Total Asset | 5.65 M | ||||
| Retained Earnings | (79.4 M) | ||||
| Working Capital | (3.3 M) | ||||
| Current Asset | 4.3 M | ||||
| Current Liabilities | 3.06 M | ||||
About Decision Diagnostics Performance
By examining Decision Diagnostics' fundamental ratios, stakeholders can obtain critical insights into Decision Diagnostics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Decision Diagnostics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 35.65 | 53.09 | |
| Return On Tangible Assets | (14.05) | (13.34) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
Things to note about Decision Diagnostics performance evaluation
Checking the ongoing alerts about Decision Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Decision Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Stock index futures rise ahead of Fed decision - MSN |
- Analyzing Decision Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Decision Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Decision Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Decision Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Decision Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Decision Diagnostics' stock. These opinions can provide insight into Decision Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state and metro area employment, hours, and earnings. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value—what Decision Diagnostics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.